Diagnosis and Treatment of Hepatocellular Carcinoma

Hashem B. El-Serag, Jorge A. Marrero, Lenhard Rudolph, K. Rajender Reddy

Research output: Contribution to journalArticle

737 Scopus citations

Abstract

The diagnosis and treatment of hepatocellular carcinoma (HCC) have witnessed major changes over the past decade. Until the early 1990s, HCC was a relatively rare malignancy, typically diagnosed at an advanced stage in a symptomatic patient, and there were no known effective palliative or therapeutic options. However, the rising incidence of HCC in several regions around the world coupled with emerging evidence for efficacy of screening in high-risk patients, liver transplantation as a curative option in select patients, ability to make definitive diagnosis using high-resolution imaging of the liver, less dependency on obtaining tissue diagnosis, and proven efficacy of transarterial chemoembolization and sorafenib as palliative therapy have improved the outlook for HCC patients. In this article, we present a summary of the most recent information on screening, diagnosis, staging, and different treatment modalities of HCC, as well as our recommended management approach.

Original languageEnglish (US)
Pages (from-to)1752-1763
Number of pages12
JournalGastroenterology
Volume134
Issue number6
DOIs
Publication statusPublished - May 2008

    Fingerprint

ASJC Scopus subject areas

  • Gastroenterology

Cite this